LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
+9.74%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.5B
AUM Growth
+$1.5B
(+69%)
Cap. Flow
+$549M
Cap. Flow
% of AUM
36.66%
Top 10 Holdings %
Top 10 Hldgs %
20.38%
Holding
396
New
274
Increased
36
Reduced
41
Closed
8
Top Buys
| 1 |
GoodRx Holdings
GDRX
|
$29.8M |
| 2 |
Thor Industries
THO
|
$26.9M |
| 3 |
Labcorp
LH
|
$23.2M |
| 4 |
Intellia Therapeutics
NTLA
|
$22.7M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
$21M |
Top Sells
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$19.6M |
| 2 |
InMode
INMD
|
$19M |
| 3 |
BEAT
BioTelemetry, Inc.
BEAT
|
$18M |
| 4 |
Futu Holdings
FUTU
|
$12.9M |
| 5 |
DexCom
DXCM
|
$11.4M |
Sector Composition
| 1 | Healthcare | 45.52% |
| 2 | Consumer Discretionary | 13.92% |
| 3 | Financials | 12.31% |
| 4 | Technology | 6.99% |
| 5 | Communication Services | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Charles Schwab
SCHW
$174B
| $36.5M | 2.42% | 559,915 -37,465 | -6% | -$2.44M |
|
2
Lowe's Companies
LOW
$145B
| $34.5M | 2.29% | 181,375 +589 | +0.3% | +$112K |
|
3
American Express
AXP
$231B
| $32.9M | 2.18% | 232,619 -27,303 | -11% | -$3.86M |
|
4
Thermo Fisher Scientific
TMO
$186B
| $30.7M | 2.04% | 67,285 +490 | +0.7% | +$224K |
|
5
Hologic
HOLX
$14.9B
| $30M | 1.99% | 403,141 +100,000 | +33% | +$7.44M |
|
|
6
GoodRx Holdings
GDRX
$1.51B
| $29.8M | 1.98% | +764,779 | New | +$29.8M |
|
7
Keysight
KEYS
$28.1B
| $29.3M | 1.94% | 204,138 -19,642 | -9% | -$2.82M |
|
8
Exact Sciences
EXAS
$8.98B
| $28.3M | 1.88% | 214,610 +144,610 | +207% | +$19.1M |
|
|
9
Thor Industries
THO
$5.79B
| $26.9M | 1.79% | +200,000 | New | +$26.9M |
|
10
Pultegroup
PHM
$26B
| $26.3M | 1.74% | 500,624 -2,053 | -0.4% | -$108K |
|
11
Voya Financial
VOYA
$7.24B
| $26.2M | 1.74% | 411,464 -88,692 | -18% | -$5.64M |
|
12
Service Corp International
SCI
$11.1B
| $25.5M | 1.69% | 500,000 +70,000 | +16% | +$3.57M |
|
13
Visa
V
$683B
| $25.5M | 1.69% | 120,378 -35,511 | -23% | -$7.52M |
|
14
Merck
MRK
$210B
| $24.5M | 1.63% | 317,806 -31,261 | -9% | -$2.41M |
|
15
Abbott
ABT
$231B
| $23.7M | 1.57% | 197,420 +32,228 | +20% | +$3.86M |
|
16
IQVIA
IQV
$32.4B
| $23.5M | 1.56% | 121,688 -50,172 | -29% | -$9.69M |
|
|
17
Futu Holdings
FUTU
$25.8B
| $23.2M | 1.54% | 146,000 -81,400 | -36% | -$12.9M |
|
|
18
Labcorp
LH
$23.1B
| $23.2M | 1.54% | +90,889 | New | +$23.2M |
|
19
AbbVie
ABBV
$372B
| $23M | 1.53% | 212,829 -88,172 | -29% | -$9.54M |
|
20
Chemed
CHE
$6.67B
| $23M | 1.53% | 50,000 +15,000 | +43% | +$6.9M |
|
|
21
Intellia Therapeutics
NTLA
$1.22B
| $22.7M | 1.51% | +282,953 | New | +$22.7M |
|
22
Brunswick
BC
$4.15B
| $21.9M | 1.46% | 230,000 +95,000 | +70% | +$9.06M |
|
|
LHCG
23
DELISTED
LHC Group LLC
LHCG
| $21M | 1.4% | +110,000 | New | +$21M |
|
24
Baidu
BIDU
$32.8B
| $20.9M | 1.39% | 96,125 -3,675 | -4% | -$799K |
|
25
Tandem Diabetes Care
TNDM
$845M
| $20.2M | 1.34% | +228,331 | New | +$20.2M |
|